ArticleTrials2022

Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial.

Dafna D Gladman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.